Ferroptosis becomes immunogenic: implications for anticancer treatments-Reference-Cited by-同舟云学术

Ferroptosis becomes immunogenic: implications for anticancer treatments

Published:2020-12-29 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Tang Daolin¹,Kepp Oliver²³^ORCID,Kroemer Guido²³⁴⁵⁶^ORCID

Affiliation:

1. Department of Surgery, UT Southwestern Medical Center, Dallas, TX, USA

2. Equipe Labellisée Par la Ligue Contre le Cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France

3. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus; 94800 Villejuif, France

4. Pôle de Biologie, Hôpital Européen Georges Pompidou, Paris, France

5. Suzhou Institute for Systems Biology, Chinese Academy of Sciences, Suzhou, China

6. Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, Sweden

Funder

Ligue contre le Cancer

Agence National de la Recherche (ANR) – Projets blancs

Association pour la recherche sur le cancer

Association “Ruban Rose”

Cancéropôle Ile-de-France

Chancelerie des universités de Paris

Fondation pour la Recherche Médicale

European Research Area Network on Cardiovascular Diseases

Gustave Roussy Odyssea, the European Union Horizon 2020 Project Oncobiome

Fondation Carrefour

High-end Foreign Expert Program in China

Institut National du Cancer

Inserm

Institut Universitaire de France

LeDucq Foundation

the LabEx Immuno-Oncology

the RHU Torino Lumière

the Seerave Foundation

the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination

SIRIC Cancer Research and Personalized Medicine

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1862949

Reference10 articles.

1. Dying cells actively regulate adaptive immune responses

2. Immunogenic and tolerogenic cell death

3. Oncolysis without viruses — inducing systemic anticancer immune responses with local therapies

4. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrinsic tumor-targeted murine Ferritin nanocage co-delivers GPX4 and FSP1 inhibitors for synergistic ferroptosis-immunotherapy;Nano Today;2024-10

2. Ferroptosis: principles and significance in health and disease;Journal of Hematology & Oncology;2024-06-06

3. Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions;Frontiers in Cell and Developmental Biology;2024-06-03

4. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches;Acta Pharmaceutica Sinica B;2024-06

5. Identification and characterization of ferroptosis-related genes in therapy-resistant gastric cancer;Medicine;2024-05-17